US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.710
  • -0.520-8.35%
Close Dec 13 16:00 ET
  • 5.810
  • +0.100+1.75%
Post 20:02 ET
483.43MMarket Cap-2.32P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-235.34%-39.61M
28.78%-34.16M
12.25%-43.08M
-22.25%-149.55M
-23.68%-40.68M
59.52%-11.81M
-79.24%-47.96M
-46.52%-49.1M
-57.08%-122.33M
-17.29%-32.89M
Net income from continuing operations
-9.56%-50.13M
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
Depreciation and amortization
19.00%1.75M
24.68%1.67M
44.81%1.63M
94.54%5.46M
64.00%1.52M
105.58%1.47M
106.33%1.34M
119.26%1.13M
82.67%2.8M
95.97%925K
Other non cash items
97.29%1.82M
-94.90%120K
89.04%1.69M
173.73%6.63M
547.91%2.46M
-79.87%923K
636.76%2.35M
175.89%894K
-93.13%2.42M
14.49%-549K
Change In working capital
-104.28%-1.12M
292.73%5.75M
-22.08%-4.04M
111.25%17.7M
-168.22%-2.22M
434.08%26.22M
-138.12%-2.98M
56.49%-3.31M
387.77%8.38M
9,670.59%3.25M
-Change in receivables
120.14%410K
208.09%2.69M
-88.03%168K
-482.21%-5.89M
-3,243.37%-2.78M
---2.04M
---2.49M
--1.4M
---1.01M
---83K
-Change in prepaid assets
-155.12%-1.82M
-992.28%-4.27M
71.44%-672K
85.10%-1.41M
1,836.76%1.18M
88.99%-713K
111.85%479K
-304.79%-2.35M
-25.35%-9.44M
96.35%-68K
-Change in payables and accrued expense
-120.94%-311K
313.49%7.11M
-771.55%-6.96M
101.59%3.68M
-64.42%1.27M
125.13%1.49M
-86.12%1.72M
90.31%-798K
-85.75%1.83M
-58.42%3.58M
-Change in other current liabilities
-15.41%-1.22M
55.60%-1.2M
21.10%-1.23M
-139.79%-7.22M
-1,017.65%-1.9M
40.99%-1.06M
-413.90%-2.7M
-199.04%-1.56M
63.24%-3.01M
97.49%-170K
-Change in other working capital
--1.82M
--1.43M
--4.65M
42.61%28.54M
--2K
----
----
----
--20.01M
--0
Cash from discontinued investing activities
Operating cash flow
-235.34%-39.61M
28.78%-34.16M
12.25%-43.08M
-22.25%-149.55M
-23.68%-40.68M
59.52%-11.81M
-79.24%-47.96M
-46.52%-49.1M
-57.08%-122.33M
-17.29%-32.89M
Investing cash flow
Cash flow from continuing investing activities
580.07%56.81M
-8.71%30.15M
-370.48%-41.63M
117.76%27.69M
94.72%-8.89M
78.68%-11.83M
324.38%33.03M
-74.39%15.39M
34.77%-155.96M
-195.36%-168.31M
Net PPE purchase and sale
11.78%-936K
63.19%-980K
87.17%-433K
29.84%-9.28M
56.02%-2.19M
59.76%-1.06M
2.10%-2.66M
-16.06%-3.38M
-203.56%-13.23M
-406.42%-4.97M
Net investment purchase and sale
636.04%57.75M
-12.77%31.13M
-319.53%-41.2M
125.91%36.97M
95.89%-6.71M
79.63%-10.77M
239.84%35.69M
-70.21%18.77M
39.20%-142.72M
-191.67%-163.35M
Cash from discontinued investing activities
Investing cash flow
580.07%56.81M
-8.71%30.15M
-370.48%-41.63M
117.76%27.69M
94.72%-8.89M
78.68%-11.83M
324.38%33.03M
-74.39%15.39M
34.77%-155.96M
-195.36%-168.31M
Financing cash flow
Cash flow from continuing financing activities
-99.96%14K
5.27%1.3M
1,015.51%22.73M
-35.38%212.58M
347.96%177.38M
-88.93%31.92M
177.08%1.23M
303.56%2.04M
-12.76%328.96M
3,135.13%39.6M
Net common stock issuance
--0
21.54%-51K
1,031.56%22.48M
-35.54%210.46M
358.21%176.82M
-88.99%31.71M
---65K
--1.99M
14.47%326.5M
--38.59M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
-93.43%14K
5.27%1.3M
159.48%301K
-20.50%2.58M
-14.25%1.02M
-80.78%213K
177.08%1.23M
-77.03%116K
85.80%3.24M
-2.95%1.19M
Net other financing activities
----
----
21.54%-51K
41.51%-458K
----
----
----
---65K
78.43%-783K
-9,000.00%-178K
Cash from discontinued financing activities
Financing cash flow
-99.96%14K
5.27%1.3M
1,015.51%22.73M
-35.38%212.58M
347.96%177.38M
-88.93%31.92M
177.08%1.23M
303.56%2.04M
-12.76%328.96M
3,135.13%39.6M
Net cash flow
Beginning cash position
95.37%146.26M
68.20%148.97M
75.45%210.95M
72.83%120.24M
-70.50%83.14M
-4.17%74.87M
-8.37%88.57M
72.83%120.24M
635.69%69.57M
83.77%281.84M
Current changes in cash
108.01%17.22M
80.22%-2.71M
-95.73%-61.98M
79.04%90.72M
179.09%127.81M
-95.94%8.28M
26.05%-13.7M
-216.89%-31.67M
-15.71%50.67M
-92.84%-161.61M
End cash Position
96.63%163.48M
95.37%146.26M
68.20%148.97M
75.45%210.95M
75.45%210.95M
-70.50%83.14M
-4.17%74.87M
-8.37%88.57M
72.83%120.24M
72.83%120.24M
Free cash flow
-214.97%-40.54M
30.59%-35.14M
17.07%-43.52M
-17.16%-158.83M
-13.22%-42.87M
59.54%-12.87M
-71.74%-50.62M
-44.09%-52.47M
-64.84%-135.56M
-30.44%-37.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -235.34%-39.61M 28.78%-34.16M 12.25%-43.08M -22.25%-149.55M -23.68%-40.68M 59.52%-11.81M -79.24%-47.96M -46.52%-49.1M -57.08%-122.33M -17.29%-32.89M
Net income from continuing operations -9.56%-50.13M 7.74%-49.81M 6.23%-48.74M -27.12%-200.07M -17.69%-48.35M -1.26%-45.76M -31.84%-53.98M -72.30%-51.98M -30.81%-157.39M -31.11%-41.09M
Depreciation and amortization 19.00%1.75M 24.68%1.67M 44.81%1.63M 94.54%5.46M 64.00%1.52M 105.58%1.47M 106.33%1.34M 119.26%1.13M 82.67%2.8M 95.97%925K
Other non cash items 97.29%1.82M -94.90%120K 89.04%1.69M 173.73%6.63M 547.91%2.46M -79.87%923K 636.76%2.35M 175.89%894K -93.13%2.42M 14.49%-549K
Change In working capital -104.28%-1.12M 292.73%5.75M -22.08%-4.04M 111.25%17.7M -168.22%-2.22M 434.08%26.22M -138.12%-2.98M 56.49%-3.31M 387.77%8.38M 9,670.59%3.25M
-Change in receivables 120.14%410K 208.09%2.69M -88.03%168K -482.21%-5.89M -3,243.37%-2.78M ---2.04M ---2.49M --1.4M ---1.01M ---83K
-Change in prepaid assets -155.12%-1.82M -992.28%-4.27M 71.44%-672K 85.10%-1.41M 1,836.76%1.18M 88.99%-713K 111.85%479K -304.79%-2.35M -25.35%-9.44M 96.35%-68K
-Change in payables and accrued expense -120.94%-311K 313.49%7.11M -771.55%-6.96M 101.59%3.68M -64.42%1.27M 125.13%1.49M -86.12%1.72M 90.31%-798K -85.75%1.83M -58.42%3.58M
-Change in other current liabilities -15.41%-1.22M 55.60%-1.2M 21.10%-1.23M -139.79%-7.22M -1,017.65%-1.9M 40.99%-1.06M -413.90%-2.7M -199.04%-1.56M 63.24%-3.01M 97.49%-170K
-Change in other working capital --1.82M --1.43M --4.65M 42.61%28.54M --2K ---- ---- ---- --20.01M --0
Cash from discontinued investing activities
Operating cash flow -235.34%-39.61M 28.78%-34.16M 12.25%-43.08M -22.25%-149.55M -23.68%-40.68M 59.52%-11.81M -79.24%-47.96M -46.52%-49.1M -57.08%-122.33M -17.29%-32.89M
Investing cash flow
Cash flow from continuing investing activities 580.07%56.81M -8.71%30.15M -370.48%-41.63M 117.76%27.69M 94.72%-8.89M 78.68%-11.83M 324.38%33.03M -74.39%15.39M 34.77%-155.96M -195.36%-168.31M
Net PPE purchase and sale 11.78%-936K 63.19%-980K 87.17%-433K 29.84%-9.28M 56.02%-2.19M 59.76%-1.06M 2.10%-2.66M -16.06%-3.38M -203.56%-13.23M -406.42%-4.97M
Net investment purchase and sale 636.04%57.75M -12.77%31.13M -319.53%-41.2M 125.91%36.97M 95.89%-6.71M 79.63%-10.77M 239.84%35.69M -70.21%18.77M 39.20%-142.72M -191.67%-163.35M
Cash from discontinued investing activities
Investing cash flow 580.07%56.81M -8.71%30.15M -370.48%-41.63M 117.76%27.69M 94.72%-8.89M 78.68%-11.83M 324.38%33.03M -74.39%15.39M 34.77%-155.96M -195.36%-168.31M
Financing cash flow
Cash flow from continuing financing activities -99.96%14K 5.27%1.3M 1,015.51%22.73M -35.38%212.58M 347.96%177.38M -88.93%31.92M 177.08%1.23M 303.56%2.04M -12.76%328.96M 3,135.13%39.6M
Net common stock issuance --0 21.54%-51K 1,031.56%22.48M -35.54%210.46M 358.21%176.82M -88.99%31.71M ---65K --1.99M 14.47%326.5M --38.59M
Net preferred stock issuance ---- ---- ---- --0 ---- ---- ---- ---- --0 ----
Proceeds from stock option exercised by employees -93.43%14K 5.27%1.3M 159.48%301K -20.50%2.58M -14.25%1.02M -80.78%213K 177.08%1.23M -77.03%116K 85.80%3.24M -2.95%1.19M
Net other financing activities ---- ---- 21.54%-51K 41.51%-458K ---- ---- ---- ---65K 78.43%-783K -9,000.00%-178K
Cash from discontinued financing activities
Financing cash flow -99.96%14K 5.27%1.3M 1,015.51%22.73M -35.38%212.58M 347.96%177.38M -88.93%31.92M 177.08%1.23M 303.56%2.04M -12.76%328.96M 3,135.13%39.6M
Net cash flow
Beginning cash position 95.37%146.26M 68.20%148.97M 75.45%210.95M 72.83%120.24M -70.50%83.14M -4.17%74.87M -8.37%88.57M 72.83%120.24M 635.69%69.57M 83.77%281.84M
Current changes in cash 108.01%17.22M 80.22%-2.71M -95.73%-61.98M 79.04%90.72M 179.09%127.81M -95.94%8.28M 26.05%-13.7M -216.89%-31.67M -15.71%50.67M -92.84%-161.61M
End cash Position 96.63%163.48M 95.37%146.26M 68.20%148.97M 75.45%210.95M 75.45%210.95M -70.50%83.14M -4.17%74.87M -8.37%88.57M 72.83%120.24M 72.83%120.24M
Free cash flow -214.97%-40.54M 30.59%-35.14M 17.07%-43.52M -17.16%-158.83M -13.22%-42.87M 59.54%-12.87M -71.74%-50.62M -44.09%-52.47M -64.84%-135.56M -30.44%-37.86M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Heat List
US
Overall
Symbol
Price
% Chg

No Data